HKSE - Delayed Quote
HKD
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
38.300
-3.700
(-8.81%)
At close: October 30 at 4:08:06 PM GMT+8
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
109.95M | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | 604,660 |
| % Change in Institutional Shares Held | 1.09% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Li (Yan) Director |
Sale at price 7.94 per share. | Direct | 2,064 | Sep 17, 2026 |
| Shen (Yuelei) Chief Executive Officer |
Other at price 5.23 per share. | Direct | 418,224 | Jun 15, 2026 |
| Li (Yan) Director |
Sale at price 5.27 per share. | Direct | 5,269 | Jan 12, 2026 |
| Li (Yan) Director |
-- | Direct | -- | Dec 31, 2025 |
| Shen (Yuelei) Chief Executive Officer |
-- | Direct | -- | Sep 26, 2025 |
| Shen (Yuelei) Chief Executive Officer |
Other at price 0.78 per share. | Direct | 470,880 | Mar 13, 2025 |
| Shen (Yuelei) Chief Executive Officer |
Other at price 0.77 per share. | Direct | 231,510 | Dec 12, 2024 |
